Alzheimer's Disease Diagnostic Paradox; New Biomarkers and Disease‐Modifying Therapies, but the Diagnosis is Still Delayed. A Real‐World Survey in Buenos Aires

We noted a significant delay between cognitive symptoms onset and the initial consultation and also several incorrect diagnoses. The new disease-modifying therapies has created an opportunity to improve AD subjects and family's life but it is imperative early and correct disease diagnosis. It is crucial to have population learning about the disease for early consultation and to improve medical knowledge for early diagnosis and treatment.